Dr. Jurgi Camblong is one of the most visionary entrepreneurs in the fast growing domain of clinical genomics. After a successful academic career in molecular biology, he moved to the start-up scene with the objective to improve patients’ diagnosis and care thanks to genomics.
After acting as CEO of Gene Predictis, he then founded Sophia Genetics in 2011 with Swiss leading geneticist Dr. Pierre Hutter and Prof. Lars Steinmetz, Professor of Genetics at Stanford University.
Since then Dr. Camblong has been successfully leading the international development of the company, recruiting the best talents and executing innovative business models.
He is today considered as one of the most successful European entrepreneurs.
Jurgi Camblong holds a PhD in Life Sciences (University of Geneva) and an EMBA in Management of Technology (EPFL-HEC Lausanne).